Economic evaluation for mass vaccination against COVID-19
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
120 Suppl 1
Date Issued
2021-06
Author(s)
Wang, Wei-Chun
Fann, Jean Ching-Yuan
Jeng, Ya-Chung
Hsu, Chen-Yang
Liu, Jin-Tan
Yen, Amy Ming-Fang
Abstract
Vaccine is supposed to be the most effective means to prevent COVID-19 as it may not only save lives but also reduce productivity loss due to resuming pre-pandemic activities. Providing the results of economic evaluation for mass vaccination is of paramount importance for all stakeholders worldwide.
Subjects
COVID-19; Cost-benefit analysis; Cost-utility analysis; Vaccine; Value of statistical life
SDGs
Other Subjects
bnt 162b 2; chadox1 ncov 19; mRNA-1273 vaccine; tozinameran; bnt 162 vaccine; ChAdOx1 COVID-19 vaccine; Article; asymptomatic coronavirus disease 2019; controlled study; coronavirus disease 2019; cost benefit analysis; cost effectiveness analysis; cost utility analysis; drug cost; drug efficacy; economic evaluation; education; health; high risk patient; hospitalization; human; major clinical study; Markov decision process; mass immunization; Monte Carlo method; outcome assessment; oxygenation; productivity; vaccination; Cost-Benefit Analysis; COVID-19; COVID-19 Vaccines; Humans; Mass Vaccination; SARS-CoV-2; Vaccination
Type
journal article